Outcomes of Volumetric-Modulated Arc Therapy for Refractory, Corticosteroid-Resistant Orbital Inflammatory Diseases
Orbital VMAT is an effective treatment for refractory, corticosteroid-resistant orbital inflammatory diseases, reducing corticosteroid use and improving ocular symptoms with minimal side effects. Further prospective clinical trials are warranted to validate more appropriate VMAT doses and planning models, enhancing treatment outcomes without increasing RT side effects.
Authors
- Xiaolin Pang (ORCID: https://orcid.org/0000-0001-7463-1559)
- Yan Ma (ORCID: https://orcid.org/0009-0004-7779-0773)
- Fang He (ORCID: https://orcid.org/0000-0002-8165-7914)
- Jian Zheng (ORCID: https://orcid.org/0000-0003-4824-9465)
- Fujing Huang
- Haiyang Chen
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Sun Yat-sen University (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-05-17
- DOI
- https://doi.org/10.1016/j.adro.2025.101811
- Primary Topic
- Ophthalmology and Eye Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Guangdong Province